Evaluating Severe Therapy-Resistant Asthma in Children: Diagnostic and Therapeutic Strategies
<i>Introduction</i>: Worldwide, asthma is the most common non-communicable respiratory disease and causes considerable morbidity and mortality. Most people with asthma can be treated effectively with low-dose medications if these are taken correctly and regularly. Around 10% of people wi...
Saved in:
Main Author: | Andrew Bush |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-11-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/60/11/1799 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Focused Overview of the 2024 Global Initiative for Asthma Guidelines
by: Farzana Hoque, et al.
Published: (2025-01-01) -
Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma
by: Amir Hossein Alizadeh Bahmani, et al.
Published: (2025-01-01) -
Perceptions, practices, and experiences of asthma patients and community pharmacists on short-acting beta-2 agonists inhaler use: A qualitative study
by: Rabia Hussain, et al.
Published: (2025-12-01) -
What prevents us from treating severe asthma well? A doctor’s perspective
by: Piotr Dąbrowiecki, et al.
Published: (2024-03-01) -
Exercise-induced bronchoconstriction in children: Delphi study and consensus document about definition and epidemiology, diagnostic work-up, treatment, and follow-up
by: Valentina Fainardi, et al.
Published: (2024-12-01)